Research study Program year 2023 Source: CMS Open Payments

Combo with PD-1 inhibitor

Research payments

$1,834,747

146 payments

Through program year 2023, $1,834,747 in research payments was reported against Combo with PD-1 inhibitor, across 146 payments, paid by Bayer HealthCare Pharmaceuticals Inc..

Paid by: Bayer HealthCare Pharmaceuticals Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$245,297	11
2022	Research	$193,364	17
2021	Research	$738,958	67
2020	Research	$492,900	33
2019	Research	$164,229	18

Breakdown

Who paid Research payments · program years 2019–2023

Bayer HealthCare Pharmaceuticals Inc. $1,834,747 146 payments

Who received the money Research payments · program years 2019–2023

Rhode Island Hospital Teaching hospital · RI $388,339 14 payments
US Oncology Research LLC Organisation paid for research $354,341 43 payments
Us Oncology Organisation paid for research $264,959 12 payments
Gabrail Cancer Center Research LLC Organisation paid for research $150,870 20 payments
Rhode Island Hospital Organisation paid for research $127,975 3 payments
Cedars-sinai Medical Center Attn: Assistant Director Post Award Services Organisation paid for research $66,571 6 payments
New York University School Of Medicine Organisation paid for research $47,208 2 payments
Northwestern University Organisation paid for research $41,922 1 payment
Cedars-Sinai Medical Center Teaching hospital · CA $40,907 5 payments
Gabrial Cancer Center Research Llc Organisation paid for research $38,739 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.